
Novel Phospholipid Signature of Depressive Symptoms in Patients With Coronary Artery Disease
Author(s) -
Chan Parco,
Suridjan Ivonne,
Mohammad Dana,
Herrmann Nathan,
Mazereeuw Graham,
Hillyer Lyn M.,
Ma David W. L.,
Oh Paul I.,
Lanctôt Krista L.
Publication year - 2018
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.117.008278
Subject(s) - medicine , coronary artery disease , depression (economics) , area under the curve , cardiology , confounding , economics , macroeconomics
Depression in patients with coronary artery disease (CAD) is associated with increased cardiovascular morbidity. Given the proinflammatory actions of phospholipids, aberrant phospholipid metabolism may be an etiological mechanism linking CAD and depression. Our primary objective was to identify a phospholipid biomarker panel that characterizes CAD patients with significant depressive symptoms from those without.